Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis

Nature Medicine

Volumn 5, Issue 7, 1999, Pages 828-831

  Moore, Robert J ^a   Owens, David M ^a   Stamp, Gordon ^b   Arnott, Caroline ^a   Burke, Frances ^a   East, Nick ^a   Holdsworth, Hazel ^a   Turner, Lynn ^a   Rollins, Barrett ^d   Pasparakis, Manolis ^c   Kollias, George ^c   Balkwill, Frances ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c HELLENIC PASTEUR INSTITUTE   (Greece)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER SUSCEPTIBILITY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; HOST RESISTANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CARCINOGENESIS;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CROSSES, GENETIC; FEMALE; IMMUNITY, NATURAL; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; NEOPLASM INVASIVENESS; NEOPLASM STAGING; SKIN; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 0032983865     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/10552     Document Type: Article

References (21)

1. Correa, P. Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 52, 6735-6740 (1992).
2. Palli, D. et al. General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: the Florence Study. Gut 42, 175-179 (1998).
3. Brown, K., and Balmain, A. Transgenic mice and squamous multistage skin carcinogenesis. Cancer Metastasis Rev. 14, 113-124 (1995).
4. Arbeit, J.A. Transgenic models of epidermal neoplasia and multistage carcinogenesis. Cancer Surv. 26, 7-34 (1996).
5. Pasparakis, M., Alexopoulou, L., Episkopou, V. & Kollias, G. Immune and inflammatory responses in TNF-α deficient mice: A critical requirement for TNF-α in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centres, and in the maturation of the humoral immune response. J. Exp. Med. 184, 1397-1411 (1996).
6. Pasparakis, M. et al. Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor. Proc. Natl. Acad. Sci. USA 94, 6319-6323 (1997)
7. Fischer S.M. et al. Correlation of phorbol ester promotion in the resistant C57BL/6J mouse with sustained hyperplasia but not ornithine decarboxylase or protein kinase C. Cancer Res. 49, 6693-6699 (1989).
8. Reiners, J.J., Nesnow, S.,& Slaga, T.J. Murine susceptibilty to two-stage skin carcinogenesis is influenced by the agent used for promotion. Carcinogenesis 5, 301-307 (1984).
9. Bradley P.P., Priebat, D.A., Christensen, R.D. & Rothstein, G. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78, 206-209 (1982).
10. Lu, B. et al. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med. 16, 601-608 (1998).
11. Komori, A. et al. Tumor necrosis factor acts as a tumor promoter in BALB/3T3 transformation. Cancer Res. 53, 1982-1985 (1993).
12. Suganuma, M. et al. A new process of cancer prevention mediated through inhibition of tumor necrosis factor o expression. Cancer Res. 56, 3711-3715 (1996).
13. Robertson, F.K. Ross, M.S., Tober, K.L., Long, B.W. & Oberyszyn, T.M. Inhibition of pro-inflammatory cytokine gene expression and papilloma growth during murine multistage carcinogenesis by pentoxifyline. Carcinogenesis 17, 1719-1728 (1996).
14. Naylor, MS, Stamp, G.W., Foulkes, W.D., Eccles, D., & Balkwill, F.R. Tumor necrosis factor and its receptors-potential in disease progression. J. Clin. Invest. 91, 2194-2206 (1993).
15. Negus, R.P.M., Turner, L., Burke, F. & Balkwill, F.R. Hypoxia down-regulates MCP-1 expression: implications for macrophage distribution in tumors. J. Leucocyte Biol. 63, 758-765 (1998).
16. Malik, S.T.A., Naylor, S., East, N., Oliff, A. & Balkwill, FR. Cells secreting tumor necrosis factor show enhanced metastasis in nude mice. Eur. J. Cancer 26, 1031-1034 (1990).
17. Orosz, P. et al. Promotion of experimental liver metastasis by tumor necrosis factor. Int. J. Cancer 60, 867-871 (1995).
18. Eggermont, A.M.M. et al. Isolated limb perfusion with high dose tumor necrosis factor-α in combination with interferon-gamma and melphalan for irresectable extremity soft tissue sarcomas: A multicentre trial. J. Clin. Oncol. 14, 2653-2665 (1996).
19. Feldmann, M., Elliott, M.J., Woody, J.N. & Maini, R.N. Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis. Adv. Immunol. 64, 283-350 (1997).
20. Wilson, A.G. et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. USA 94, 3195-3197 (1997).
21. Warzocha, K. et al. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood 91, 3574-3581 (1998).